NURS 6630N-5, WEEK 11 FINAL EXAM 300
ACTUAL QUESTIONS AND CORRECT ANSWERS
WITH RATIONALE LATEST UPDATE ALREADY
GRADED A+
This comprehensive 300-question bank for NURS 6630N-5 Week 11 Final
Exam covers psychopharmacology and neurobiology across the lifespan.
Topics include depression, anxiety, bipolar disorder, schizophrenia, ADHD,
substance use disorders, Alzheimer's disease, and pain management.
Questions address neurotransmitter pathways, receptor mechanisms, FDA-
approved indications, black box warnings, side effect monitoring, drug
interactions, and treatment strategies for special populations. Each unique
question includes multiple-choice options, a correct answer, and a detailed
evidence-based rationale. This resource reinforces clinical decision-making,
pharmacokinetic principles, and guideline-based prescribing for psychiatric
mental health nurse practitioners preparing for board certification and
advanced practice.
1. A 55-year-old male with frontotemporal dementia was laughing inappropriately
at a funeral and later became irritated with himself. Which medication is
recommended to help with these emotional outbursts?
A) Haloperidol
B) Fluoxetine
C) Citalopram
D) Donepezil
Answer: B
Rationale: SSRIs like fluoxetine are often used to manage the emotional lability
and behavioral symptoms associated with frontotemporal dementia .
2. A patient with treatment-resistant major depressive disorder requires an
intervention with strong evidence for rapid reduction of suicidal ideation. Which is
the most appropriate choice?
A) Fluoxetine
,B) Buspirone
C) Esketamine nasal spray
D) Mirtazapine
Answer: C
Rationale: Esketamine nasal spray has demonstrated rapid antidepressant effects
and reduction of suicidal ideation in treatment-resistant depression, unlike
traditional antidepressants which take weeks to work .
3. Excessive dopamine activity in which brain pathway is primarily associated with
the positive symptoms of schizophrenia?
A) Mesocortical pathway
B) Mesolimbic pathway
C) Nigrostriatal pathway
D) Tuberoinfundibular pathway
Answer: B
Rationale: The dopamine hypothesis proposes that positive symptoms
(hallucinations, delusions) are linked to hyperactivity in the mesolimbic pathway .
4. Which laboratory value should be monitored routinely in a patient receiving
lithium therapy?
A) Hemoglobin A1C
B) Vitamin B12
C) Serum creatinine
D) Uric acid
Answer: C
Rationale: Lithium can affect renal function; serum creatinine is routinely
monitored to detect nephrogenic diabetes insipidus or other renal issues .
5. A patient with Alzheimer’s disease who has irritable bowel syndrome is being
started on a cholinergic drug. Which is the best choice to minimize gastrointestinal
side effects?
A) Donepezil
B) Rivastigmine
C) Galantamine
D) Memantine
Answer: A
Rationale: Donepezil may be better tolerated in patients with GI issues compared
to other cholinesterase inhibitors .
,6. A 75-year-old male with Alzheimer’s disease presents with agitation and
aggressive behavior. What is considered a best treatment option?
A) Haloperidol
B) Citalopram or Escitalopram
C) Lorazepam
D) Bupropion
Answer: B
Rationale: SSRIs like citalopram or escitalopram are often preferred for managing
agitation and aggression in Alzheimer's to avoid the risks of antipsychotics .
7. A patient with hypersexual disorder is being assessed. Why might a PMHNP
prescribe an antiandrogen?
A) To increase serotonin
B) To block testosterone
C) To decrease dopamine
D) To increase GABA
Answer: B
Rationale: Antiandrogens work by blocking testosterone, which can reduce
hypersexual behaviors .
8. A patient on quetiapine complains of constipation. This side effect is most likely
caused by the binding of quetiapine to which receptor?
A) Muscarinic-1 (M1)
B) Dopamine D2
C) Histamine H1
D) Serotonin 5-HT2A
Answer: A
Rationale: Constipation is an anticholinergic side effect, often resulting from M1
receptor antagonism .
9. Varenicline is effective for smoking cessation because it acts as a:
A) Nicotinic acetylcholine receptor antagonist
B) Selective nicotinic acetylcholine receptor partial agonist
C) Dopamine reuptake inhibitor
D) Serotonin antagonist
Answer: B
Rationale: Varenicline is a partial agonist at nicotinic acetylcholine receptors,
reducing cravings and withdrawal symptoms .
10. Milnacipran is most likely prescribed for which condition?
, A) Major depressive disorder
B) Fibromyalgia
C) Generalized anxiety disorder
D) Insomnia
Answer: B
Rationale: Milnacipran is an SNRI FDA-approved for the management of
fibromyalgia .
11. Memantine is considered for Alzheimer’s patients exhibiting symptoms of:
A) Amnesia, apraxia, agnosia
B) Depression and anxiety
C) Wandering and sleep disturbances
D) Repetitive movements
Answer: A
Rationale: Memantine is an NMDA receptor antagonist used in moderate to severe
Alzheimer's, targeting symptoms like amnesia and agnosia .
12. In the pathophysiology of Alzheimer's disease, which protein is associated with
plaques, and which with tangles?
A) Tau for plaques, Amyloid-beta for tangles
B) Amyloid-beta for plaques, Tau for tangles
C) Dopamine for plaques, Serotonin for tangles
D) Acetylcholine for plaques, Glutamate for tangles
Answer: B
Rationale: Amyloid-beta plaques and tau neurofibrillary tangles are the hallmark
pathologies of Alzheimer's disease .
13. A patient with vascular dementia presents with memory loss and motor system
slowing after many small strokes. What is the recommended treatment approach?
A) Cholinesterase inhibitors
B) Control of vascular risk factors
C) Antipsychotics
D) Memantine
Answer: B
Rationale: Treatment for vascular dementia primarily focuses on managing
underlying vascular risk factors (hypertension, hyperlipidemia) to prevent further
strokes .
14. Which medication used in Alzheimer's disease requires a slow titration to avoid
Stevens-Johnson syndrome?
ACTUAL QUESTIONS AND CORRECT ANSWERS
WITH RATIONALE LATEST UPDATE ALREADY
GRADED A+
This comprehensive 300-question bank for NURS 6630N-5 Week 11 Final
Exam covers psychopharmacology and neurobiology across the lifespan.
Topics include depression, anxiety, bipolar disorder, schizophrenia, ADHD,
substance use disorders, Alzheimer's disease, and pain management.
Questions address neurotransmitter pathways, receptor mechanisms, FDA-
approved indications, black box warnings, side effect monitoring, drug
interactions, and treatment strategies for special populations. Each unique
question includes multiple-choice options, a correct answer, and a detailed
evidence-based rationale. This resource reinforces clinical decision-making,
pharmacokinetic principles, and guideline-based prescribing for psychiatric
mental health nurse practitioners preparing for board certification and
advanced practice.
1. A 55-year-old male with frontotemporal dementia was laughing inappropriately
at a funeral and later became irritated with himself. Which medication is
recommended to help with these emotional outbursts?
A) Haloperidol
B) Fluoxetine
C) Citalopram
D) Donepezil
Answer: B
Rationale: SSRIs like fluoxetine are often used to manage the emotional lability
and behavioral symptoms associated with frontotemporal dementia .
2. A patient with treatment-resistant major depressive disorder requires an
intervention with strong evidence for rapid reduction of suicidal ideation. Which is
the most appropriate choice?
A) Fluoxetine
,B) Buspirone
C) Esketamine nasal spray
D) Mirtazapine
Answer: C
Rationale: Esketamine nasal spray has demonstrated rapid antidepressant effects
and reduction of suicidal ideation in treatment-resistant depression, unlike
traditional antidepressants which take weeks to work .
3. Excessive dopamine activity in which brain pathway is primarily associated with
the positive symptoms of schizophrenia?
A) Mesocortical pathway
B) Mesolimbic pathway
C) Nigrostriatal pathway
D) Tuberoinfundibular pathway
Answer: B
Rationale: The dopamine hypothesis proposes that positive symptoms
(hallucinations, delusions) are linked to hyperactivity in the mesolimbic pathway .
4. Which laboratory value should be monitored routinely in a patient receiving
lithium therapy?
A) Hemoglobin A1C
B) Vitamin B12
C) Serum creatinine
D) Uric acid
Answer: C
Rationale: Lithium can affect renal function; serum creatinine is routinely
monitored to detect nephrogenic diabetes insipidus or other renal issues .
5. A patient with Alzheimer’s disease who has irritable bowel syndrome is being
started on a cholinergic drug. Which is the best choice to minimize gastrointestinal
side effects?
A) Donepezil
B) Rivastigmine
C) Galantamine
D) Memantine
Answer: A
Rationale: Donepezil may be better tolerated in patients with GI issues compared
to other cholinesterase inhibitors .
,6. A 75-year-old male with Alzheimer’s disease presents with agitation and
aggressive behavior. What is considered a best treatment option?
A) Haloperidol
B) Citalopram or Escitalopram
C) Lorazepam
D) Bupropion
Answer: B
Rationale: SSRIs like citalopram or escitalopram are often preferred for managing
agitation and aggression in Alzheimer's to avoid the risks of antipsychotics .
7. A patient with hypersexual disorder is being assessed. Why might a PMHNP
prescribe an antiandrogen?
A) To increase serotonin
B) To block testosterone
C) To decrease dopamine
D) To increase GABA
Answer: B
Rationale: Antiandrogens work by blocking testosterone, which can reduce
hypersexual behaviors .
8. A patient on quetiapine complains of constipation. This side effect is most likely
caused by the binding of quetiapine to which receptor?
A) Muscarinic-1 (M1)
B) Dopamine D2
C) Histamine H1
D) Serotonin 5-HT2A
Answer: A
Rationale: Constipation is an anticholinergic side effect, often resulting from M1
receptor antagonism .
9. Varenicline is effective for smoking cessation because it acts as a:
A) Nicotinic acetylcholine receptor antagonist
B) Selective nicotinic acetylcholine receptor partial agonist
C) Dopamine reuptake inhibitor
D) Serotonin antagonist
Answer: B
Rationale: Varenicline is a partial agonist at nicotinic acetylcholine receptors,
reducing cravings and withdrawal symptoms .
10. Milnacipran is most likely prescribed for which condition?
, A) Major depressive disorder
B) Fibromyalgia
C) Generalized anxiety disorder
D) Insomnia
Answer: B
Rationale: Milnacipran is an SNRI FDA-approved for the management of
fibromyalgia .
11. Memantine is considered for Alzheimer’s patients exhibiting symptoms of:
A) Amnesia, apraxia, agnosia
B) Depression and anxiety
C) Wandering and sleep disturbances
D) Repetitive movements
Answer: A
Rationale: Memantine is an NMDA receptor antagonist used in moderate to severe
Alzheimer's, targeting symptoms like amnesia and agnosia .
12. In the pathophysiology of Alzheimer's disease, which protein is associated with
plaques, and which with tangles?
A) Tau for plaques, Amyloid-beta for tangles
B) Amyloid-beta for plaques, Tau for tangles
C) Dopamine for plaques, Serotonin for tangles
D) Acetylcholine for plaques, Glutamate for tangles
Answer: B
Rationale: Amyloid-beta plaques and tau neurofibrillary tangles are the hallmark
pathologies of Alzheimer's disease .
13. A patient with vascular dementia presents with memory loss and motor system
slowing after many small strokes. What is the recommended treatment approach?
A) Cholinesterase inhibitors
B) Control of vascular risk factors
C) Antipsychotics
D) Memantine
Answer: B
Rationale: Treatment for vascular dementia primarily focuses on managing
underlying vascular risk factors (hypertension, hyperlipidemia) to prevent further
strokes .
14. Which medication used in Alzheimer's disease requires a slow titration to avoid
Stevens-Johnson syndrome?
